Regulation of OGT by URI in Response to Glucose Confers c-MYC-Dependent Survival Mechanisms

Cancer Cell

Volumn 30, Issue 2, 2016, Pages 290-307

  Burén, Stefan ^a   Gomes, Ana L ^a   Teijeiro, Ana ^a   Fawal, Mohamad Ali ^a   Yilmaz, Mahmut ^a   Tummala, Krishna S ^a   Perez, Manuel ^a   Rodriguez Justo, Manuel ^b   Campos Olivas, Ramón ^a   Megías, Diego ^a   Djouder, Nabil ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; MYC PROTEIN; O LINKED N ACETYLGLUCOSAMINE TRANSFERASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1 GAMMA; TRANSFERASE; UNCLASSIFIED DRUG; UNCONVENTIONAL PREFOLDIN RPB5 INTERACTOR; MYC PROTEIN, HUMAN; MYC PROTEIN, MOUSE; N ACETYLGLUCOSAMINYLTRANSFERASE; SIGNAL PEPTIDE; SMALL INTERFERING RNA; URI1 PROTEIN, HUMAN;

ACYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; O GLCNACYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; ANIMAL; GENETIC TRANSFECTION; GENETICS; GLUCOSE TOLERANCE TEST; HEK293 CELL LINE; HELA CELL LINE; LIVER TUMOR; METABOLISM;

ANIMALS; GLUCOSE; GLUCOSE TOLERANCE TEST; HEK293 CELLS; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MICE; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84989968256     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.06.023     Document Type: Article

References (39)

1. Allen, M.D., Zhang, J., Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters. Biochem. Biophys. Res. Commun. 348 (2006), 716–721.
2. Anderson, A.R., Weaver, A.M., Cummings, P.T., Quaranta, V., Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127 (2006), 905–915.
3. Bollen, M., Peti, W., Ragusa, M.J., Beullens, M., The extended PP1 toolkit: designed to create specificity. Trends Biochem. Sci. 35 (2010), 450–458.
4. Caldwell, S.A., Jackson, S.R., Shahriari, K.S., Lynch, T.P., Sethi, G., Walker, S., Vosseller, K., Reginato, M.J., Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 29 (2010), 2831–2842.
5. Dang, C.V., MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb. Perspect. Med., 3, 2013, 10.1101/cshperspect.a014217.
6. Danial, N.N., Gramm, C.F., Scorrano, L., Zhang, C.Y., Krauss, S., Ranger, A.M., Datta, S.R., Greenberg, M.E., Licklider, L.J., Lowell, B.B., et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424 (2003), 952–956.
7. Delmore, J.E., Issa, G.C., Lemieux, M.E., Rahl, P.B., Shi, J., Jacobs, H.M., Kastritis, E., Gilpatrick, T., Paranal, R.M., Qi, J., et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146 (2011), 904–917.
8. Djouder, N., Metzler, S.C., Schmidt, A., Wirbelauer, C., Gstaiger, M., Aebersold, R., Hess, D., Krek, W., S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes activates a negative feedback program that counters S6K1 survival signaling. Mol. Cell 28 (2007), 28–40.
9. Doege, K., Heine, S., Jensen, I., Jelkmann, W., Metzen, E., Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood 106 (2005), 2311–2317.
10. Ferrer, C.M., Lynch, T.P., Sodi, V.L., Falcone, J.N., Schwab, L.P., Peacock, D.L., Vocadlo, D.J., Seagroves, T.N., Reginato, M.J., O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Mol. Cell 54 (2014), 820–831.
11. Gerlee, P., Anderson, A.R., An evolutionary hybrid cellular automaton model of solid tumour growth. J. Theor. Biol. 246 (2007), 583–603.
12. Gerlee, P., Anderson, A.R., Diffusion-limited tumour growth: simulations and analysis. Math. Biosci. Eng. 7 (2010), 385–400.
13. Gibbons, J.A., Weiser, D.C., Shenolikar, S., Importance of a surface hydrophobic pocket on protein phosphatase-1 catalytic subunit in recognizing cellular regulators. J. Biol. Chem. 280 (2005), 15903–15911.
14. Gomes, A., Teijeiro, A., Buren, S., Tummala, K., Yilmaz, M., Waisman, A., Theurilat, J.P., Perna, C., Djouder, N., Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma. Cancer Cell 30 (2016), 161–175.
15. Griffith, L.S., Schmitz, B., O-linked N-acetylglucosamine levels in cerebellar neurons respond reciprocally to pertubations of phosphorylation. Eur. J. Biochem. 262 (1999), 824–831.
16. Hardiville, S., Hart, G.W., Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab. 20 (2014), 208–213.
17. Hart, G.W., Akimoto, Y., The O-GlcNAc modification. Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E., (eds.) Essentials of Glycobiology, 2009, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY Chapter 18.
18. Kamemura, K., Hayes, B.K., Comer, F.I., Hart, G.W., Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J. Biol. Chem. 277 (2002), 19229–19235.
19. Konrad, R.J., Zhang, F., Hale, J.E., Knierman, M.D., Becker, G.W., Kudlow, J.E., Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem. Biophys. Res. Commun. 293 (2002), 207–212.
20. Lazarus, M.B., Nam, Y., Jiang, J., Sliz, P., Walker, S., Structure of human O-GlcNAc transferase and its complex with a peptide substrate. Nature 469 (2011), 564–567.
21. Love, D.C., Kochan, J., Cathey, R.L., Shin, S.H., Hanover, J.A., Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J. Cell Sci. 116 (2003), 647–654.
22. Ma, Z., Vosseller, K., Cancer metabolism and elevated O-GlcNAc in oncogenic signaling. J. Biol. Chem. 289 (2014), 34457–34465.
23. Ma, L., Tao, Y., Duran, A., Llado, V., Galvez, A., Barger, J.F., Castilla, E.A., Chen, J., Yajima, T., Porollo, A., et al. Control of nutrient stress-induced metabolic reprogramming by PKCzeta in tumorigenesis. Cell 152 (2013), 599–611.
24. Okuyama, H., Endo, H., Akashika, T., Kato, K., Inoue, M., Downregulation of c-MYC protein levels contributes to cancer cell survival under dual deficiency of oxygen and glucose. Cancer Res. 70 (2010), 10213–10223.
25. Pathak, S., Borodkin, V.S., Albarbarawi, O., Campbell, D.G., Ibrahim, A., van Aalten, D.M., O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release. EMBO J. 31 (2012), 1394–1404.
26. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., Comoglio, P.M., Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3 (2003), 347–361.
27. Qu, A., Jiang, C., Cai, Y., Kim, J.H., Tanaka, N., Ward, J.M., Shah, Y.M., Gonzalez, F.J., Role of Myc in hepatocellular proliferation and hepatocarcinogenesis. J. Hepatol. 60 (2014), 331–338.
28. Shim, H., Chun, Y.S., Lewis, B.C., Dang, C.V., A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. USA 95 (1998), 1511–1516.
29. Slawson, C., Copeland, R.J., Hart, G.W., O-GlcNAc signaling: a metabolic link between diabetes and cancer?. Trends Biochem. Sci. 35 (2010), 547–555.
30. Soucek, L., Evan, G.I., The ups and downs of Myc biology. Curr. Opin. Genet. Dev. 20 (2010), 91–95.
31. Takanaga, H., Chaudhuri, B., Frommer, W.B., GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. Biochim. Biophys. Acta 1778 (2008), 1091–1099.
32. Theurillat, J.P., Metzler, S.C., Henzi, N., Djouder, N., Helbling, M., Zimmermann, A.K., Jacob, F., Soltermann, A., Caduff, R., Heinzelmann-Schwarz, V., et al. URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell 19 (2011), 317–332.
33. Tummala, K.S., Gomes, A.L., Yilmaz, M., Grana, O., Bakiri, L., Ruppen, I., Ximenez-Embun, P., Sheshappanavar, V., Rodriguez-Justo, M., Pisano, D.G., et al. Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. Cancer Cell 26 (2014), 826–839.
34. Wells, L., Kreppel, L.K., Comer, F.I., Wadzinski, B.E., Hart, G.W., O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. J. Biol. Chem. 279 (2004), 38466–38470.
35. Wick, A.N., Drury, D.R., Nakada, H.I., Wolfe, J.B., Localization of the primary metabolic block produced by 2-deoxyglucose. J. Biol. Chem. 224 (1957), 963–969.
36. Yun, J., Rago, C., Cheong, I., Pagliarini, R., Angenendt, P., Rajagopalan, H., Schmidt, K., Willson, J.K., Markowitz, S., Zhou, S., et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325 (2009), 1555–1559.
37. Zhang, Z., Tan, E.P., VandenHull, N.J., Peterson, K.R., Slawson, C., O-GlcNAcase expression is sensitive to changes in O-GlcNAc homeostasis. Front Endocrinol., 5, 2014, 206.
38. Zhu, Q., Zhou, L., Yang, Z., Lai, M., Xie, H., Wu, L., Xing, C., Zhang, F., Zheng, S., O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Med. Oncol. 29 (2012), 985–993.
39. Zhu, G., Tao, T., Zhang, D., Liu, X., Qiu, H., Han, L., Xu, Z., Xiao, Y., Cheng, C., Shen, A., O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression. Glycobiology, 2016, 1–14, 10.1093/glycob/cww025.